跳转至内容
Merck
CN
  • Aggregates of mutant CFTR fragments in airway epithelial cells of CF lungs: new pathologic observations.

Aggregates of mutant CFTR fragments in airway epithelial cells of CF lungs: new pathologic observations.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society (2014-12-03)
Kai Du, Philip H Karp, Cameron Ackerley, Joseph Zabner, Shaf Keshavjee, Ernest Cutz, Herman Yeger
摘要

Cystic fibrosis (CF) is caused by a mutation in the CF transmembrane conductance regulator (CFTR) gene resulting in a loss of Cl(-) channel function, disrupting ion and fluid homeostasis, leading to severe lung disease with airway obstruction due to mucus plugging and inflammation. The most common CFTR mutation, F508del, occurs in 90% of patients causing the mutant CFTR protein to misfold and trigger an endoplasmic reticulum based recycling response. Despite extensive research into the pathobiology of CF lung disease, little attention has been paid to the cellular changes accounting for the pathogenesis of CF lung disease. Here we report a novel finding of intracellular retention and accumulation of a cleaved fragment of F508del CFTR in concert with autophagic like phagolysosomes in the airway epithelium of patients with F508del CFTR. Aggregates consisting of poly-ubiquitinylated fragments of only the N-terminal domain of F508del CFTR but not the full-length molecule accumulate to appreciable levels. Importantly, these undegraded intracytoplasmic aggregates representing the NT-NBD1 domain of F508del CFTR were found in ciliated, in basal, and in pulmonary neuroendocrine cells. Aggregates were found in both native lung tissues and ex-vivo primary cultures of bronchial epithelial cells from CF donors, but not in normal control lungs. Our findings present a new, heretofore, unrecognized innate CF gene related cell defect and a potential contributing factor to the pathogenesis of CF lung disease. Mutant CFTR intracytoplasmic aggregates could be analogous to the accumulation of misfolded proteins in other degenerative disorders and in pulmonary "conformational protein-associated" diseases. Consequently, potential alterations to the functional integrity of airway epithelium and regenerative capacity may represent a critical new element in the pathogenesis of CF lung disease.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
Protease Inhibitor Cocktail, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
E-64, protease inhibitor
Sigma-Aldrich
抗-兔IgG(全分子)-过氧化物酶 山羊抗, affinity isolated antibody, buffered aqueous solution
Supelco
Pefabloc® SC
Sigma-Aldrich
甲基丙烯酸异氰基乙酯, contains ≤0.1% BHT as inhibitor, 98%
Sigma-Aldrich
4-(2-氨乙基)苯磺酰氟 盐酸盐, ≥97.0% (HPLC)
Sigma-Aldrich
抗山羊 IgG(全分子)-过氧化物酶 兔抗, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
(±)- L -蒜氨酸, ≥90% (HPLC)
Sigma-Aldrich
苯丁抑制素 盐酸盐, ≥98% (HPLC)
Sigma-Aldrich
抗小鼠IgG(全分子)-过氧化物酶 山羊抗, IgG fraction of antiserum, buffered aqueous solution
Supelco
, analytical standard